News
True or False: Eating more pro-inflammatory foods was associated with worse overall survival in patients with stage III colon ...
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...
1d
MedPage Today on MSNGLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA WarnsA potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...
1d
HealthDay on MSNProlonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye ConditionPeople who use popular diabetes drugs called GLP-1 receptor agonists may be at increased risk for a serious eye disease, a ...
A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...
Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...
Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
4d
HealthDay on MSNASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause DeathProtective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes. (HealthDay News) — For adults with diabetes and obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results